HSF1 and prostate carcinoma: In this study a clinical significance of HSF1 in prostate cancer is demonstrated: increased HSF1 expression associates with disease progression and independently predicts initiation of secondary therapy and poor disease-specific survival of prostate cancer patients after radical prostatectomy.